Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial

被引：2

作者：

Knudsen, Trine A. ^{[1
]}

Hansen, Dennis Lund ^{[2
]}

Ocias, Lukas Frans ^{[2
]}

Bjerrum, Ole Weis ^{[3
]}

Brabrand, Mette ^{[2
]}

Christensen, Sarah F. ^{[1
]}

Eickhardt-Dalboge, Christina Schjellerup S. ^{[1
]}

Ellervik, Christina ^{[4
,5
,6
,7
,8
]}

El Fassi, Daniel ^{[3
,9
]}

Frederiksen, Mikael ^{[10
]}

Kjaer, Lasse ^{[1
]}

Kristensen, Thomas Kielsgaard ^{[11
]}

Kruse, Torben A. ^{[12
]}

Larsen, Morten Kranker ^{[1
]}

Mourits-Andersen, Torben ^{[13
]}

Overgaard, Ulrik Malthe ^{[3
]}

Severinsen, Marianne Tang ^{[14
]}

Skov, Vibe ^{[1
]}

Sorensen, Anders Lindholm ^{[1
]}

Stentoft, Jesper ^{[15
]}

Starklint, Jorn ^{[16
]}

de Stricker, Karin ^{[11
]}

Thomassen, Mads ^{[12
]}

Larsen, Thomas S. ^{[2
]}

Hasselbalch, Hans Carl ^{[1
,9
]}

机构：

[1] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark

[2] Odense Univ Hosp, Dept Hematol, Odense, Denmark

[3] Copenhagen Univ Hosp, Rigshosp, Dept Hematol, Copenhagen, Denmark

[4] Reg Zealand, Dept Data & Data Support, Soro, Denmark

[5] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark

[6] Reg Zealand, Dept Prod Res & Innovat, Soro, Denmark

[7] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA

[8] Harvard Med Sch, Dept Pathol, Boston, MA USA

[9] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark

[10] Hosp Southern Jutland, Dept Hematol, Aabenraa, Denmark

[11] Odense Univ Hosp, Dept Pathol, Odense, Denmark

[12] Odense Univ Hosp, Dept Clin Genet, Odense, Denmark

[13] Hosp South West Jutland, Dept Hematol, Esbjerg, Denmark

[14] Aalborg Univ Hosp, Dept Hematol, Aalborg, Denmark

[15] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark

[16] Hosp West Jutland, Dept Hematol, Holstebro, Denmark

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-156445

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1794 / 1796

页数：3

共 50 条

[21] Quality of life in schizophrenia: results from a naturalistic randomized controlled trial in Brazil
de Lima, MS
Mari, JJ
Costa, AM
Alexandrino, N
Filho, SR
de Oliveira, IR
ACTA PSYCHIATRICA SCANDINAVICA, 2002, 105 : 19 - 20
[22] Effect of amantadine on quality of life and fatigue in patients with chronic hepatitis C participating in a prospective, double blind, placebo controlled, randomized trial of treatment with pegylated interferon alfa2a/ribavirin
Formann, E
Jessner, W
Hubmann, R
Datz, C
Munda-Steindl, P
Klingler, A
Moser, G
Ferenci, P
HEPATOLOGY, 2004, 40 (04) : 338A - 338A
[23] The effect of Reiki therapy on quality of life of patients with blood cancer: Results from a randomized controlled trial
Alarcao, Zilda
Fonseca, Jaime R. S.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2016, 8 (03) : 239 - 249
[24] Cancer symptom burden negatively affects health-related quality of life in patients undergoing prehabilitation prior to liver resection: results from a 12-week randomized controlled trial
Kasvis, Popi
Vigano, Antonio
Bui, Tram
Carli, Franco
Kilgour, Robert D.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2024, 49 (01) : 64 - 76
[25] RANDOMIZED TRIAL COMPARING SYSTEMIC AND LOCAL REACTIONS TO CONTROLLED-RELEASE INTERFERON ALPHA2B AND PEGYLATED-INTERFERON ALPHA2B IN HEPATITIS C PATIENTS WHO FAILED PRIOR TREATMENT
Lawitz, E.
Younossi, Z. M.
Shiffman, M.
Gordon, S.
Ghalib, R.
Long, W.
Muir, A.
McHutchison, J.
JOURNAL OF HEPATOLOGY, 2009, 50 : S231 - S231
[26] CRESCENDO: Results from a survey of symptom burden and quality of life in patients with narcolepsy type 1
Doghramji, Karl
Thorpy, Michael
Kant, Amy
Harper, Keith
Leary, Eileen
Parks, Gregory
Floam, Samantha
Tabuteau, Herriot
JOURNAL OF SLEEP RESEARCH, 2024, 33
[27] Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial
Mesa, Ruben A.
Kosiorek, Heidi E.
Mascarenhas, John
Prchal, Josef T.
Rambaldi, Alessandro
Berenzon, Dmitriy
Yacoub, Abdulraheem
Harrison, Claire N.
McMullin, Mary Frances
Vannucchi, Alessandro M.
Ewing, Joanne
O'Connell, Casey L.
Kiladjian, Jean-Jacques
Mead, Adam J.
Winton, Elliott F.
Leibowitz, David S.
De Stefano, Valerio
Arcasoy, Murat O.
Kessler, Craig M.
Catchatourian, Rosalind
Rondelli, Damiano
Silver, Richard T.
Bacigalupo, Andrea
Nagler, Arnon
Kremyanskaya, Marina
Sandy, Lonette
Salama, Mohamed E.
Najfeld, Vesna
Tripodi, Joseph
Weinberg, Rona Singer
Rampal, Raajit K.
Hoffman, Ronald
Dueck, Amylou C.
BLOOD, 2018, 132
[28] Effects of a Home-Based Palliative Heart Failure Program on Quality of Life, Symptom Burden, Satisfaction and Caregiver Burden: A Randomized Controlled Trial
Ng, Alina Yee Man
Wong, Frances Kam Yuet
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2018, 55 (01) : 1 - 11
[29] Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon alpha-2b and ribavirin in chronic hepatitis C genotype 4: A randomized trial and quality of life analysis (vol 31, pg 401, 2011)
Kamal, S. M.
Ahmed, A.
Mahmoud, S.
LIVER INTERNATIONAL, 2011, 31 (04) : 588 - 588
[30] Ruxopeg, a Multi-Center Bayesian Phase 1/2 Adaptive Randomized Trial of the Combination of Ruxolitinib and Pegylated Interferon Alpha 2a in Patients with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis
Kiladjian, Jean-Jacques
Soret-Dulphy, Juliette
Resche-Rigon, Matthieu
Boyer-Perrard, Francoise
Barraco, Fiorenza
Rolland-Neyret, Valerie
Capron, Claude
Chevret, Sylvie
Giraudier, Stephane
Cassinat, Bruno
BLOOD, 2018, 132

← 1 2 3 4 5 →